Annual Drug Patent Expirations for CARAC
Carac is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CARAC.
The generic ingredient in CARAC is fluorouracil. Three suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com